Browsing: Volume 1 Issue 3 – December 2025
Two new reports from insurance asset manager Conning – one of them produced in conjunction with life settlement industry group the European Life Settlement Association (ELSA), publisher of Longevity and Mortality Investor – paint an optimistic picture of the state of the life settlement market.
Reasons abound as to why the inclusion of illiquid assets in the portfolios of defined benefit pension schemes can be a hindrance to the process of completing a bulk purchase annuity buy-in or buy-out in the UK but insurer appetite to capitalise on the booming pension risk transfer market means that any resistance is not as pronounced as it was previously.
As with previous years, the US life insurance industry had a solid 2024 from a balance sheet perspective and continues to be healthy from a risk perspective.
Longevity and Mortality Investor’s Editor’s Letter for the December 2025 issue.
New PRA discussion paper provides insight into the UK regulator’s thinking on potential reforms to the existing ISPV regime.
The life insurance stress test initiative this year finds the UK life insurance industry’s collective solvency coverage ratio to be well above regulatory requirements.
The past four decades have brought revolutionary improvements in cancer care, transforming many forms of cancer from fatal diagnoses into chronic, manageable conditions.
For those in the longevity and mortality modelling game, 2025 has provided plenty of activity to keep the actuaries busy. Greg Winterton spoke to James Hadley, Senior Consultant at Barnett Waddingham, to learn more about what is front and centre of the conversation in his world as the year draws to a close.